Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Biohit Oyj Director's Dealing 2017

Oct 11, 2017

3304_dirs_2017-10-11_ee52f8b2-a599-483c-9c89-ce09fa3ec328.html

Director's Dealing

Open in viewer

Opens in your device viewer

Disclosure 355494

Biohit Oyj - Managers' transactions

Biohit Oyj - Managers' Transactions

Biohit Oyj - Managers' Transactions, October 11, 2017 at 9:30 am. local time (EEST)

Biohit Oyj has received the following notification.

Person subject to the notification requirement
Name: Oy Tech Know Ltd Legal Person
Position: Closely associated person
Person discharging managerial responsibilities in issuer
Name: Matti Härkönen
Position: Member of the Board/Deputy member
Initial Notification
Reference number: 74370089ATTSNBXJVT29_20171009105215_7
Issuer
Name: Biohit Oyj
LEI: 74370089ATTSNBXJVT29
Transaction details
Transaction date: 2017-10-06
Venue: OFF-EXCHANGE TRANSACTIONS (XOFF)
Nature of the transaction: Disposal
Instrument: Share
ISIN: FI0009005482
Volume: 26400
Unit price: 5,38000 Euro
Aggregated transactions
Volume: 26400
Volume weighted average price: 5.38000 Euro

Additional information:

CEO Semi Korpela, Biohit Oyj

tel. +358 9 773 861

[email protected]

www.biohithealthcare.com

Biohit in brief

Biohit Oyj is a globally operating Finnish biotechnology company. Biohit’s mission is “Innovating for Health” – we produce innovative products and services to promote research and early diagnosis. Biohit is headquartered in Helsinki, Finland, and has subsidiaries in Italy and the UK. Biohit's Series B share (BIOBV) is quoted on Nasdaq Helsinki in the Small cap/Healthcare group. www.biohithealthcare.com